FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/08/004806 [Registered on: 01/08/2014] Trial Registered Retrospectively
Last Modified On: 31/07/2014
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison between Dexmedetomidine and Fentanyl for pain relief after abdominal surgeries. 
Scientific Title of Study   COMPARISON OF ANALGESIC EFFICACY OF DEXMEDETOMIDINE VERSUS FENTANYL AS AN ADJUNCT TO THORACIC EPIDURAL WITH BUPIVACAINE IN PATIENTS UNDERGOING UPPER ABDOMINAL SURGERY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shweta Nandkumar Pokale 
Designation  Junior Resident 
Affiliation  Postgraduate Institute Of Medical Education And Research 
Address  Department of Anaesthesia, PGIMER, Sector 12
Sector 12, Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  9814012468  
Fax    
Email  snp1986@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neerja Bharti 
Designation  Associate Professor 
Affiliation  Postgraduate Institute Of Medical Education And Research 
Address  Department of Anaesthesia, PGIMER, Sector 12
Sector 12, Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  9914209527  
Fax    
Email  bhartineerja@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Shweta Nandkumar Pokale 
Designation  Junior Resident 
Affiliation  Postgraduate Institute Of Medical Education And Research 
Address  Department of Anaesthesia, PGIMER, Sector 12
Sector 12, Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  9814012468  
Fax    
Email  snp1986@gmail.com  
 
Source of Monetary or Material Support  
PostGraduate institute of medical education and research Chandigarh 
 
Primary Sponsor  
Name  PostGraduate institute of medical education and research 
Address  PostGraduate institute of medical education and research,sector 12, Chandigarh, chandigarh-160012 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shweta N Pokale  department of anaesthesia  post graduate institute of medical education and research,chandigarh-160012
Chandigarh
CHANDIGARH 
9814012468

snp1986@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Intramural Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  scheduled for hepaticojejunostomy,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  dexmedetomidine  50 mics with 10 ml of 0.125% bupivacaine in thoracic epidural,intraoperatively.post-operatively 1 mics/ml dexmedetomidine with 0.125% bupivacaine-3ml bolus via PCEA pump with 15 min lock-out interval 
Comparator Agent  Fentanyl  50 mics with 10 ml of 0.125% bupivacaine in thoracic epidural intraoperatively.post-operatively 1 mics/ml fentanyl with 0.125% bupivacaine-3ml bolus via PCEA pump with 15 min lock-out interval 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA Class I and II, undergoing elective hepaticojejunostomy 
 
ExclusionCriteria 
Details  • BMI>35 kg/sq metre
• Renal or hepatic dysfunction
• Known cardiovascular disorder
• Patients on beta-blockers, on long term treatment of antipsychotic drugs
• Known allergy or senstivity to dexmedetomidine, bupivacaine or fentanyl
• Contraindication to insertion of epidural catheter (local infection, spine deformities etc.)
• Alcohol abuse, heavy smoking
• Inability to use PCEA device
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
postoperative pain and analgesic requirements  24 hours postoperatively 
 
Secondary Outcome  
Outcome  TimePoints 
intraoperative analgesia and hemodynamic parameters  assessed every 5 min after start of epidural infusion for 30 min ,every 15 min till end of surgery. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   02/05/2013 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   not published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   the purpose of the study was to compare and quantify the analgesic efficacy of dexmedetomoidine and fentanyl when both were used as an adjunct to thoracic epidural in patients undergoing hepaticojejunostomy under general anaesthesia. the addition of dexmededtomidine to 0.125% bupivacaine intraoperatively and postoperatively significantly reduces the requirement of bupivacaine as compared to fentanyl with comparable hemodynamic stability. the total consumption of rescue analgesia was significantly lower in dexmedetomidine group as compared to fentanyl group. the postoperative pain scores were comparable throughout the study between two groups and patients in dexmedetomidine group were more sedated.The heart rate was significantly lower in dexmedetomidine group as compared to fentanyl though the other haemodynamic parameters were comparable throughout the study.two patients in fentanyl group developed PONV whereas 2 patients in dexmed group developed mild nausea.no other side effects were reported in either of the two groups. 
Close